SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-03-023170
Filing Date
2003-07-02
Accepted
2003-07-01 21:55:44
Documents
5
Period of Report
2003-07-01
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2114193z8-k.htm 8-K 10812
3 EXHIBIT 10.1 a2114193zex-10_1.htm EX-10.1 103224
4 EXHIBIT 10.2 a2114193zex-10_2.htm EX-10.2 64285
5 EXHIBIT 10.3 a2114193zex-10_3.htm EX-10.3 48436
6 EXHIBIT 99.1 a2114193zex-99_1.htm EX-99.1 8410
  Complete submission text file 0001047469-03-023170.txt   237297
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 03769452
SIC: 2835 In Vitro & In Vivo Diagnostic Substances